Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy
Table 1
Clinical parameters and biochemical findings at admission.
Clinical parameter (unit)
Value
Reference range
Blood pressure (mmHg)
98/47
Heart rate (beats per minute)
132
Respiratory rate (breaths per minute)
40
Peripheral blood oxygen saturation (%)
90
Venous blood tests (unit)
Lactate (mmol/L)
5.5
0.9–1.7
Creatinine (µmol)
145
45–90
Sodium (mmol/L)
136
137–145
Potassium (mmol/L)
4.9
3.5–5.0
Urea (mmol/L)
10.9
2.6–6.4
Leucocytes (109/L)
17.5
3.5–11.0
Neutrophils (109/L)
13.4
1.7–8.2
C-reactive protein (mg/L)
198
<5
Procalcitonin (µg/L)
0.25
<0.10
Troponin T (ng/L)
213
≤14
NT-proBNP (ng/L)
5644
<169
D-dimer (mg/L FEU)
>4.00
<0.50
Arterial blood gas (unit)
Arterial partial pressure of oxygen (kPa)
9.3
>10.1
Arterial partial pressure of CO2 (kPa)
2.7
4.5–6.1
pH
7.43
7.36–7.44
Base excess
−10.2
−3–+3
Arterial HCO3
13
22–26
Notes: In room air. Test taken with 4 L/minute oxygen supplement on the nasal cannula.
